Back to results
US 2021/0198753 A1Published application
Systems and methods for determining a treatment course of action
AssigneeArizona Board of Regents on Behalf of the University of Arizona
InventorsGhassan Mouneimne, Marco Padilla-Rodriguez
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods of determining a treatment course of action. In particular, the present disclosure relates to compositions and methods for determining responsiveness to estrogen and estrogen blocking therapies for cancer.
Claims18
A method of treating cancer, comprising:
- a) assaying a sample from a subject diagnosed with cancer for the level of expression of Enah/Vasp-Like gene (EVL) and estrogen receptor;
- and
- b) administering anti-estrogen therapy when said sample is positive for estrogen receptor expression and level of expression of EVL is lower than a reference level and not administering anti-estrogen therapy when the level of expression of EVL is higher than said reference level.
A method of treating cancer, comprising:
- a) assaying a sample from a subject diagnosed with cancer for the level of expression of i) a tumor marker selected from the group consisting of EVL, TMSB15B, TMSB15B, MYO10, ANLN, TNNT1, ABLIM3, FMNL2, and LIMA1 and ii) estrogen receptor;
- and
- b) administering anti-estrogen therapy when said level of expression of said tumor marker is lower than a reference level and not administering anti-estrogen therapy when the level of expression of said tumor marker is higher than said reference level.
A method of treating cancer, comprising:
- a) assaying a sample from a subject diagnosed with breast cancer for the level of expression of EVL;
- and
- b) administering estrogen therapy when said level of expression of EVL is lower than a reference level.
17-20. (canceled)
Dependencies are inferred from the claim text.